Conclusions:
The DurAVR THV FIH study results at one-year demonstrate that the biomimetic design restores near-normal function through the unique single-piece native shaped valve with evidence of improved safety and hemodynamic performance
FIH 12 mth results published in Heart Lung Circulation, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
-0.380(2.42%) |
Mkt cap ! $335.8M | |||
| Open | High | Low | Value | Volume |
| $15.70 | $15.94 | $15.03 | $210.0K | 13.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 890 | $15.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 16 | 1 |
View Market Depth
| Last trade - 12.00pm 19/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |